Lorazepam Injection
Product Images NDC 0641-6207
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 0641-6207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Premier Container Label (Lorazepam Injection Usp Premierprorx 2)
This is a description of a medication labeled "Lorazepam." The medication has a National Drug Code (NDC) of 0641-6207-01, comes in a 1mL vial, and is suitable for intramuscular use. The medication should be diluted if used intravenously and must be protected from light and refrigerated. There is also information related to lot number and expiration, but that text is not readable.*
Premier Shelfpack Label (Lorazepam Injection Usp Premierprorx 3)
NDC 0641-6207-25 is a prescription drug called Lorazepam Injection, USP, usually used for Intramuscular or Intravenous use. Each mL of the solution contains 2 mg lorazepam, and it may require dilution before Intravenous use. The solution should be refrigerated and protected from light. The package comes with a carton and 25 x 1 mL Vials. For dosage, refer to the insert provided. It is essential not to use a solution that is discolored or contains a precipitate. The solution is manufactured by Hima Bercl Hoghts, and the brand is PREMIERProRx®.*
Lorazepam Injection Usp Premierprorx 4
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.